// Daily US stock report
October 29, 2026
Premarket and post-market candidates with catalyst context and Trend Join Long scanner decisions.
04:00-09:30 ET
Premarket Scan
08:55 ET scan: 10 candidates were checked. None passed both trend conditions; five passed the daily breakout but did not exceed the completed-minute premarket high, and five failed the daily trend test.
| Symbol | Market cap | Premarket price | Gap | Premarket volume | 20-day average volume | Premarket / average | What probably caused it | Why it fit the premarket candidate filter | Why it fit the trend scanner report or failed to fit the trend scanner |
|---|---|---|---|---|---|---|---|---|---|
| CROX | $5.74B | $141.025 | +17.83% | 93,802 | 1,038,598.6 | 9.03% | Crocs reported third-quarter results and raised its 2026 EPS forecast to $14.45-$14.65, while lifting its full-year revenue-growth outlook to about 3%. Likely catalyst. | At the candidate scan it had a $5.74B market cap, a $141.025 premarket price, a 17.83% gap, 93,802 premarket shares, and premarket volume equal to 9.03% of its 20-day average. | fail_intraday. daily breakout passed: current price 144.000 > prior-day high 121.000 and prior close 119.690 > SMA200 109.258750; premarket breakout failed: current price 144.000 <= PMH 144.654. |
| INSM | $21.18B | $110.000 | +13.43% | 374,738 | 3,264,561.3 | 11.48% | Insmed reported third-quarter revenue of $524.4 million, BRINSUPRI revenue of $400.1 million, and raised 2026 revenue guidance for both BRINSUPRI and ARIKAYCE. Confirmed catalyst. | At the candidate scan it had a $21.18B market cap, a $110.000 premarket price, a 13.43% gap, 374,738 premarket shares, and premarket volume equal to 11.48% of its 20-day average. | fail_daily. current price 112.900 > prior-day high 97.915; prior close 96.980 <= SMA200 125.931875. Premarket comparison: current price 112.900 <= PMH 118.080. |
| TDOC | $1.25B | $7.750 | +12.65% | 72,443 | 3,865,599.9 | 1.87% | Teladoc reported third-quarter revenue of $605.1 million near the upper end of guidance and adjusted EBITDA of $79.4 million, up 14% and above its guidance range. Confirmed catalyst. | At the candidate scan it had a $1.25B market cap, a $7.750 premarket price, a 12.65% gap, 72,443 premarket shares, and premarket volume equal to 1.87% of its 20-day average. | fail_intraday. daily breakout passed: current price 7.720 > prior-day high 6.920 and prior close 6.880 > SMA200 6.451450; premarket breakout failed: current price 7.720 <= PMH 7.960. |
| NCLH | $7.37B | $17.912 | +11.53% | 2,118,205 | 19,725,548.75 | 10.74% | Norwegian Cruise Line delivered third-quarter results above guidance and raised full-year 2026 adjusted EBITDA and EPS guidance. Confirmed catalyst. | At the candidate scan it had a $7.37B market cap, a $17.912 premarket price, a 11.53% gap, 2,118,205 premarket shares, and premarket volume equal to 10.74% of its 20-day average. | fail_daily. current price 17.880 > prior-day high 16.150; prior close 16.060 <= SMA200 18.748250. Premarket comparison: current price 17.880 <= PMH 18.340. |
| PURR | $2.77B | $10.840 | +8.73% | 3,121,668 | 11,936,554.6 | 26.15% | No reliable fresh same-day catalyst was found. A recent filing showed an expanded stock-repurchase authorization to $100 million, but linking that older event to today's move is only an inference. No confirmed catalyst. | At the candidate scan it had a $2.77B market cap, a $10.840 premarket price, a 8.73% gap, 3,121,668 premarket shares, and premarket volume equal to 26.15% of its 20-day average. | fail_intraday. daily breakout passed: current price 11.121 > prior-day high 9.985 and prior close 9.970 > SMA200 7.576775; premarket breakout failed: current price 11.121 <= PMH 11.750. |
| BHC | $2.59B | $7.520 | +8.67% | 61,390 | 2,250,034.65 | 2.73% | Bausch Health reported third-quarter revenue of $2.94 billion, adjusted EPS growth of 53%, adjusted EBITDA growth of 32%, and raised its 2026 revenue, EBITDA, and cash-flow guidance. Confirmed catalyst. | At the candidate scan it had a $2.59B market cap, a $7.520 premarket price, a 8.67% gap, 61,390 premarket shares, and premarket volume equal to 2.73% of its 20-day average. | fail_intraday. daily breakout passed: current price 7.780 > prior-day high 6.970 and prior close 6.920 > SMA200 5.689000; premarket breakout failed: current price 7.780 <= PMH 7.780. |
| CVNA | $64.98B | $64.040 | +8.45% | 120,377 | 8,612,583.2 | 1.40% | Carvana reported record third-quarter retail units, revenue of $8.04 billion, net income of $483 million, and adjusted EBITDA of $800 million. Confirmed catalyst. | At the candidate scan it had a $64.98B market cap, a $64.040 premarket price, a 8.45% gap, 120,377 premarket shares, and premarket volume equal to 1.40% of its 20-day average. | fail_daily. current price 64.700 > prior-day high 60.450; prior close 59.050 <= SMA200 186.321300. Premarket comparison: current price 64.700 <= PMH 65.100. |
| CMG | $36.36B | $31.110 | +8.28% | 330,471 | 23,327,619.6 | 1.42% | Chipotle reported third-quarter revenue growth of 9.6% to $3.3 billion and comparable-sales growth of 2.1%, with positive transaction growth for a third consecutive quarter. Confirmed catalyst. | At the candidate scan it had a $36.36B market cap, a $31.110 premarket price, a 8.28% gap, 330,471 premarket shares, and premarket volume equal to 1.42% of its 20-day average. | fail_daily. current price 31.118 > prior-day high 29.240; prior close 28.730 <= SMA200 34.140600. Premarket comparison: current price 31.118 <= PMH 31.350. |
| DASH | $73.44B | $182.000 | +7.38% | 173,781 | 3,513,550.45 | 4.95% | DoorDash reported record quarterly Marketplace GOV, revenue, and net income, and announced a definitive agreement to acquire Instacart for $65 per share. Confirmed catalyst. | At the candidate scan it had a $73.44B market cap, a $182.000 premarket price, a 7.38% gap, 173,781 premarket shares, and premarket volume equal to 4.95% of its 20-day average. | fail_daily. current price 181.540 > prior-day high 173.800; prior close 169.490 <= SMA200 183.062125. Premarket comparison: current price 181.540 <= PMH 189.220. |
| LITE | $82.79B | $965.800 | +5.67% | 284,738 | 5,060,159.9 | 5.63% | A same-day report said Marvell was in talks to acquire Lumentum. The report is a plausible catalyst, but no company confirmation was found. Likely catalyst. | At the candidate scan it had a $82.79B market cap, a $965.800 premarket price, a 5.67% gap, 284,738 premarket shares, and premarket volume equal to 5.63% of its 20-day average. | fail_intraday. daily breakout passed: current price 980.000 > prior-day high 921.000 and prior close 913.950 > SMA200 795.837150; premarket breakout failed: current price 980.000 <= PMH 984.640. |
Average volume is the mean regular-session volume over the latest 20 completed trading days. Higher relative volume indicates stronger participation, but it does not prove that a breakout is real or durable.
09:30-20:00 ET
Regular + Post-market Scan
20:49 ET scan: 4 candidates were checked. MDLZ passed both trend conditions; CDNA and INGM passed the daily breakout but did not hold within 2% of their post-market highs, while RIVN failed the daily trend test.
| Symbol | Market cap | Post-market price | Gap | Daily + post-market volume | 20-day average volume | Daily + post-market / average | What probably caused it | Why it fit the post-market candidate filter | Why it fit the trend scanner report or failed to fit the trend scanner |
|---|---|---|---|---|---|---|---|---|---|
| CDNA | $3.70B | $82.250 | +15.00% | 1,797,245 Regular 1,692,144 · post-market 105,101 | 1,340,527.4 | 134.07% | CareDx reported third-quarter revenue of $139 million, up 39% year over year, and raised its 2026 revenue and adjusted EBITDA guidance. Confirmed catalyst. | At the candidate scan it had a $3.70B market cap, an $82.250 post-market price, a 15.00% gap, 105,101 post-market shares, and combined volume equal to 134.07% of its 20-day average. | fail_postmarket. Daily breakout passed: post-market price 82.250 > regular high 73.080 and regular close 71.520 > SMA200 33.305575. Post-market hold failed: 82.250 < 98% of the 85.130 post-market high (83.427400). |
| MDLZ | $79.81B | $66.664 | +6.61% | 8,279,208 Regular 7,830,802 · post-market 448,406 | 7,334,399.5 | 112.88% | Mondelēz reported third-quarter net revenue growth of 2.3%, organic net revenue growth of 2.1%, positive volume/mix, and diluted EPS growth of 78.9%. Confirmed catalyst. | At the candidate scan it had a $79.81B market cap, a $66.664 post-market price, a 6.61% gap, 448,406 post-market shares, and combined volume equal to 112.88% of its 20-day average. | PASS. Post-market price 66.664 > regular high 62.660; regular close 62.530 > SMA200 60.350450; and 66.664 >= 98% of the 68.000 post-market high (66.640000). |
| INGM | $6.60B | $30.450 | +6.43% | 3,117,582 Regular 2,511,406 · post-market 606,176 | 1,388,168.1 | 224.58% | Ingram Micro reported record third-quarter results with double-digit growth in net sales and net income, strong cash generation, and raised full-year guidance. Confirmed catalyst. | At the candidate scan it had a $6.60B market cap, a $30.450 post-market price, a 6.43% gap, 606,176 post-market shares, and combined volume equal to 224.58% of its 20-day average. | fail_postmarket. Daily breakout passed: post-market price 30.450 > regular high 29.070 and regular close 28.610 > SMA200 26.364250. Post-market hold failed: 30.450 < 98% of the 31.630 post-market high (30.997400). |
| RIVN | $16.58B | $12.100 | +5.68% | 46,163,675 Regular 43,236,244 · post-market 2,927,431 | 25,844,340.05 | 178.62% | Rivian released third-quarter 2026 results showing revenue of $2.155 billion, up 38% year over year, while its net loss narrowed. Confirmed catalyst. | At the candidate scan it had a $16.58B market cap, a $12.100 post-market price, a 5.68% gap, 2,927,431 post-market shares, and combined volume equal to 178.62% of its 20-day average. | fail_daily. Post-market price 12.100 > regular high 11.870, but regular close 11.450 <= SMA200 15.489150. Post-market hold passed: 12.100 >= 98% of the 12.330 post-market high (12.083400). |
Average volume is the mean regular-session volume over the 20 completed trading days before today. Higher relative volume indicates participation, not proof that a breakout is real or durable.
Research only. This is not investment advice, and no trade is placed by either scanner.